Sulfadiazine revisited.
M G
MG
Ventura
J
J
Wybran
C M
CM
Farber
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000900:Anti-Bacterial Agents; D001927:Brain Diseases / Q000188:drug therapy* / Q000209:etiology; D003460:Crystallization; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000009:adverse effects* / Q000627:therapeutic use / Q000652:urine; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D013411:Sulfadiazine; D011739:Pyrimethamine